Sichuan Cunde Therapeutics Co.
Latest round
- Series A
Last raised
- Sep 2025
Total raised
- Undisclosed
Investors
- 3
About Sichuan Cunde Therapeutics Co.
, Ltd is a biopharmaceutical companies' company that focuses on diagnosis and treatment research services and product development of major disease, such as tumors and liver cirrhosis., Ltd. The company has received the national 13th Five-Year Major New Drug Innovation and Technology Major Special support. Its products obtained the first bath of products supported by the Sichuan provincial Drug Administration in the early intervention implementation plan for new drug R&D. The company operates the development, transformation, and application of new cell therapy technologies in the field of human diseases, such as malignant tumors and liver cirrhosis. It self-developed Cunde technology platform that is a personalized tumor vaccine development platform. According to the patient's personalized tumor neoantigens, autologous dendritic cells are used as carriers to improve the recognition of tumors cells by the human immune system and improve the immunogenicity of tumor cells to kill tumor cells, inhibit tumor growth, and reduce tumor recurrence. Specific product includes therapeutic tumor vaccine, therapeutic tumor vaccine, and individualized anti-liver fibrosis macrophage injection. Revenue is generated through hardware sales, custom integration projects, and long-term supply agreements with industrial clients. Additional income may come from embedded software support and technical services.
Who invested in Sichuan Cunde Therapeutics Co.
3 investors across 2 rounds
See all investors in Sichuan Cunde Therapeutics Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sichuan Cunde Therapeutics Co.
Who invested in Sichuan Cunde Therapeutics Co.?
Sichuan Cunde Therapeutics Co. has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sichuan Cunde Therapeutics Co. raised?
Sichuan Cunde Therapeutics Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Sichuan Cunde Therapeutics Co. last raise money?
Sichuan Cunde Therapeutics Co.'s most recent round on record is a Series A, in Sep 2025.
What does Sichuan Cunde Therapeutics Co. do?
, Ltd is a biopharmaceutical companies' company that focuses on diagnosis and treatment research services and product development of major disease, such as tumors and liver cirrhosis.
Where is Sichuan Cunde Therapeutics Co. headquartered?
Sichuan Cunde Therapeutics Co. is headquartered in Chengdu, China.
Which VCs invest in companies like Sichuan Cunde Therapeutics Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at Sichuan Cunde Therapeutics Co.'s stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Sichuan Cunde Therapeutics Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.